ATLAS fair value
ATLAS has no fair value for this stock today.
Chiron Real Estate stock price today, ATLAS forecast and fair value
Real Estate · REIT - Healthcare Facilities · NYSE
Prices as of Oct 27, 2026 · USD
ATLAS has no fair value for this stock today.
50%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Chiron Real Estate a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $27.31 and $30.76; in 9 out of 10, between $24.58 and $34.18. Estimated annual volatility is 36%.
ATLAS does not publish a fair value for XRN right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks XRN has traded between $28.49 and $38.65. Today it is 25.1% below that high and 2% above its low.
On the business: revenue grew 6.7% year over year; net margin is 4.7%; it trades at 10.0 times earnings.
Its beta is 1.13: it moves roughly in line with the market.
Chiron Real Estate Inc. is a healthcare-focused real estate investment trust that owns and manages purpose-built medical properties.
Want to see everything about Chiron Real Estate?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Chiron Real Estate Inc. is a healthcare-focused real estate investment trust that owns and manages purpose-built medical properties.
50%: close to a coin flip. In half of the simulated outcomes, XRN ends the month between $27.31 and $30.76.
Chiron Real Estate's market capitalization is $492M. Its price-to-earnings (P/E) ratio is 10.0: you pay $10.0 for each $1 of yearly earnings.
Yes. XRN's current dividend yield is 7.94% at today's price ($28.96).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy